Department of Medicine, University of Illinois at Chicago.
Department of Medicine, Massachusetts General Hospital, Harvard University, Boston.
JAMA Cardiol. 2021 Jul 1;6(7):811-819. doi: 10.1001/jamacardio.2021.0994.
Although rare variants in cardiac ion channels, transcription factors, and myocardial structural proteins are associated with early-onset atrial fibrillation (AF) in White individuals of European descent, it remains unclear whether genetic variation also contributes to the cause of AF in those of minority ethnicity.
To assess the prevalence of rare and novel pathogenic variants in candidate genes in ethnic minority probands with early-onset AF and determine genotype-phenotype associations.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort, family-based study, probands of African and Hispanic descent with early-onset AF (defined as AF occurring in individuals aged ≤66 years) prospectively enrolled in a clinical and genetic biorepository underwent sequencing of 60 candidate genes. Recruitment took place from July 1, 2015, to June 30, 2019. Data were analyzed from February 1 to February 28, 2020.
Rare and novel variants categorized as pathogenic or likely pathogenic.
The prevalence of rare and novel pathogenic variants in African American and Hispanic/Latinx probands with early-onset AF and genotype-phenotype associations.
Among 227 probands with early-onset AF, mean (SD) age at onset of AF was 51.0 (9.9) years, 132 probands (58.1%) were men, 148 (65.2%) were African American, and 79 (34.8%) were Hispanic/Latinx. A family history of AF was verified in 24 probands with early-onset AF (10.6%). Sequencing 60 candidate genes identified 53 (23 rare and 30 novel) variants with 16 of the 227 (7.0%) probands harboring likely pathogenic (43.8%) or pathogenic (56.2%) variants, with most loss-of-function variants in TTN, the gene encoding the sarcomeric protein titin (46.7%). In 6 families with more than 2 affected members, variants of unknown significance in sodium channel (SCN10A), potassium channel (KCNE5), sarcomeric proteins (MYH6 and TTN), and atrial natriuretic peptide (NPPA) cosegregated with AF.
In this study, likely pathogenic and pathogenic variants were identified, with most loss-of-function variants in TTN, that increase susceptibility to early-onset AF in African American and Hispanic/Latinx individuals. These findings provide further understanding toward molecular phenotyping of AF and suggest novel mechanism-based therapeutic approaches for this common arrhythmia in ethnic minority groups.
尽管心脏离子通道、转录因子和心肌结构蛋白的罕见变异与欧洲裔白种人早发性心房颤动(AF)有关,但遗传变异是否也导致少数族裔人群的 AF 发病仍不清楚。
评估候选基因中罕见和新的致病性变异在早发性 AF 的少数族裔先证者中的患病率,并确定基因型-表型相关性。
设计、地点和参与者:在这项队列、基于家族的研究中,前瞻性纳入了早发性 AF(定义为发生在≤66 岁个体中的 AF)的非洲裔和西班牙裔先证者,这些先证者来自临床和遗传生物库。对 60 个候选基因进行了测序。招募工作于 2015 年 7 月 1 日至 2019 年 6 月 30 日进行。数据分析于 2020 年 2 月 1 日至 2 月 28 日进行。
归类为致病性或可能致病性的罕见和新型致病变异。
早发性 AF 的非裔美国人和西班牙裔/拉丁裔先证者中罕见和新型致病性变异的患病率以及基因型-表型相关性。
在 227 例早发性 AF 先证者中,AF 发病的平均(SD)年龄为 51.0(9.9)岁,132 例(58.1%)为男性,148 例(65.2%)为非裔美国人,79 例(34.8%)为西班牙裔/拉丁裔。24 例早发性 AF 先证者中有 24 例(10.6%)证实有 AF 家族史。对 60 个候选基因进行测序发现了 53 个(23 个罕见和 30 个新型)变异,227 例先证者中有 16 例(7.0%)携带可能致病性(43.8%)或致病性(56.2%)变异,其中编码肌节蛋白肌联蛋白(TTN)的基因 TTN 中大多数为功能丧失变异(46.7%)。在 6 个有 2 个以上受影响成员的家族中,钠通道(SCN10A)、钾通道(KCNE5)、肌节蛋白(MYH6 和 TTN)和心钠肽(NPPA)的意义不明变异与 AF 共分离。
在这项研究中,确定了可能致病性和致病性变异,其中 TTN 中大多数为功能丧失变异,增加了非裔美国人和西班牙裔/拉丁裔个体早发性 AF 的易感性。这些发现为 AF 的分子表型提供了进一步的理解,并为少数族裔人群的这种常见心律失常提供了新的基于机制的治疗方法。